StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Ironwood Pharmaceuticals's EV/EBITDA was 3.1× on Nov 10, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 0.1× to 10.9×, with a median of 4.8×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20263.1×−0.3
2025Dec 31, 20253.3×−2.9
2024Dec 31, 20246.3×+2.4
2023Jul 31, 20233.9×−1.7
2022Dec 30, 20225.6×−0.8
2021Dec 31, 20216.4×−4.3
2020Dec 31, 202010.7×−8.7
2019Dec 31, 201919.4×–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?